Afinitor plus Somatuline significantly improved PFS in GEP-NETs compared to Afinitor monotherapy, with median PFS of 29.7 vs. 11.5 months. The combination therapy showed a higher objective response ...
Association of health insurance types and out-of-pocket expenses with clinical outcomes among patients with head and neck cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback